JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/jme.0.0250035

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (59)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bulun, S.
Right arrow Articles by Sasano, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bulun, S.
Right arrow Articles by Sasano, H
Journal of Molecular Endocrinology, Vol 25, Issue 1, 35-42
Copyright © 2000 by Society for Endocrinology


Articles

Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance

SE Bulun, KM Zeitoun, K Takayama, and H Sasano


Conversion of C(19) steroids to estrogens is catalyzed by aromatase in human ovary, placenta and extraglandular tissues such as adipose tissue, skin and the brain. Aromatase activity is not detectable in normal endometrium. In contrast, aromatase is expressed aberrantly in endometriosis and is stimulated by prostaglandin E(2) (PGE(2)).( )This results in local production of estrogen, which induces PGE(2) formation and establishes a positive feedback cycle. Another abnormality in endometriosis, i.e. deficient hydroxysteroid dehydrogenase (17beta-HSD) type 2 expression, impairs the inactivation of estradiol to estrone. These molecular aberrations collectively favor accumulation of increasing quantities of estradiol and PGE(2 )in endometriosis. The clinical relevance of these findings was exemplified by the successful treatment of an unusually aggressive case of postmenopausal endometriosis using an aromatase inhibitor.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
E. M. C. Ohlsson Teague, C. G. Print, and M. L. Hull
The role of microRNAs in endometriosis and associated reproductive conditions
Hum. Reprod. Update, September 22, 2009; (2009) dmp034v1.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. H. Collins, E. C. Lessey, C. D. DuSell, D. P. McDonnell, L. Fowler, W. A. Palomino, M. J. Illera, X. Yu, B. Mo, A. M. Houwing, et al.
Characterization of Antiestrogenic Activity of the Chinese Herb, Prunella vulgaris, Using In Vitro and In Vivo (Mouse Xenograft) Models
Biol Reprod, February 1, 2009; 80(2): 375 - 383.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J. M Day, H. J Tutill, A. Purohit, and M. J Reed
Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
Endocr. Relat. Cancer, September 1, 2008; 15(3): 665 - 692.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson
Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis
Endocrinology, March 1, 2008; 149(3): 1190 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. Hudelist, K. Czerwenka, J. Keckstein, C. Haas, A. Fink-Retter, D. Gschwantler-Kaulich, E. Kubista, and C.F. Singer
Expression of Aromatase and Estrogen Sulfotransferase in Eutopic and Ectopic Endometrium: Evidence for Unbalanced Estradiol Production in Endometriosis
Reproductive Sciences, December 1, 2007; 14(8): 798 - 805.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
C. M. Becker, R. D. Wright, R. Satchi-Fainaro, T. Funakoshi, J. Folkman, A. L. Kung, and R. J. D'Amato
A Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy
Am. J. Pathol., June 1, 2006; 168(6): 2074 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. M D'Hooghe, N. P. Nugent, S. Cuneo, D. C. Chai, F. Deer, S. Debrock, C. M. Kyama, A. Mihalyi, and J. M. Mwenda
Recombinant Human TNFRSF1A (r-hTBP1) Inhibits the Development of Endometriosis in Baboons: A Prospective, Randomized, Placebo- and Drug-Controlled Study
Biol Reprod, January 1, 2006; 74(1): 131 - 136.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie
Is dehydroepiandrosterone a hormone?
J. Endocrinol., November 1, 2005; 187(2): 169 - 196.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.L. Hull, A. Prentice, D.Y. Wang, R.P. Butt, S.C. Phillips, S.K. Smith, and D.S. Charnock-Jones
Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis
Hum. Reprod., February 1, 2005; 20(2): 350 - 358.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. H. Seo, H.-S. Lee, B. Jung, H.-M. Ko, J.-H. Choi, S. J. Park, I.-H. Choi, H.-K. Lee, and S.-Y. Im
Estrogen Enhances Angiogenesis through a Pathway Involving Platelet-Activating Factor-Mediated Nuclear Factor-{kappa}B Activation
Cancer Res., September 15, 2004; 64(18): 6482 - 6488.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
R. Varma, T. Rollason, J. K Gupta, and E. R Maher
Endometriosis and the neoplastic process
Reproduction, March 1, 2004; 127(3): 293 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Akoum, A. Lemay, and R. Maheux
Estradiol and Interleukin-1{beta} Exert a Synergistic Stimulatory Effect on the Expression of the Chemokine Regulated upon Activation, Normal T Cell Expressed, and Secreted in Endometriotic Cells
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5785 - 5792.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M.-H. Wu, H.S. Sun, C.-C. Lin, K.-Y. Hsiao, P.-C. Chuang, H.-A. Pan, and S.-J. Tsai
Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis
Mol. Hum. Reprod., December 1, 2002; 8(12): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-J. Yang, M. Shozu, K. Murakami, H. Sumitani, T. Segawa, T. Kasai, and M. Inoue
Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3745 - 3753.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Conley, S. Mapes, C. J. Corbin, D. Greger, and S. Graham
Structural Determinants of Aromatase Cytochrome P450 Inhibition in Substrate Recognition Site-1
Mol. Endocrinol., July 1, 2002; 16(7): 1456 - 1468.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M.-H. Wu, P.-C. Chuang, H.-M. Chen, C.-C. Lin, and S.-J. Tsai
Increased leptin expression in endometriosis cells is associated with endometrial stromal cell proliferation and leptin gene up-regulation
Mol. Hum. Reprod., May 1, 2002; 8(5): 456 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S.-J. Tsai, M.-H. Wu, C.-C. Lin, H. S. Sun, and H.-M. Chen
Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal Cells
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5765 - 5773.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Lamminmaki and J. A. Kankare
Crystal Structure of a Recombinant Anti-estradiol Fab Fragment in Complex with 17beta -Estradiol
J. Biol. Chem., September 21, 2001; 276(39): 36687 - 36694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Endocrinology.